Fingerprint
Dive into the research topics of 'Phase Ia study of anti-NAPI2B antibody–drug conjugate lifastuzumab vedotin DNIB0600A in patients with non–small cell lung cancer and platinum-resistant ovarian cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically